Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4564700
Max Phase: Preclinical
Molecular Formula: C82H58O52
Molecular Weight: 1875.31
Molecule Type: Unknown
Associated Items:
ID: ALA4564700
Max Phase: Preclinical
Molecular Formula: C82H58O52
Molecular Weight: 1875.31
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(O[C@@H]1O[C@@H]2COC(=O)c3cc(O)c(O)c(O)c3-c3c(cc(O)c(O)c3O)C(=O)O[C@H]2[C@H](OC(=O)c2cc(O)c(O)c(O)c2)[C@H]1OC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(Oc2c(C(=O)O[C@H]3[C@H](OC(=O)c4cc(O)c(O)c(O)c4)O[C@@H]4COC(=O)c5cc(O)c(O)c(O)c5-c5c(cc(O)c(O)c5O)C(=O)O[C@H]4[C@@H]3OC(=O)c3cc(O)c(O)c(O)c3)cc(O)c(O)c2O)c(O)c1
Standard InChI: InChI=1S/C82H58O52/c83-28-1-18(2-29(84)49(28)98)71(112)129-67-65-43(16-122-76(117)23-11-36(91)53(102)58(107)45(23)47-25(78(119)127-65)13-38(93)55(104)60(47)109)124-81(69(67)131-73(114)20-5-32(87)51(100)33(88)6-20)134-75(116)22-9-41(96)64(42(97)10-22)126-63-27(15-40(95)57(106)62(63)111)80(121)132-70-68(130-72(113)19-3-30(85)50(99)31(86)4-19)66-44(125-82(70)133-74(115)21-7-34(89)52(101)35(90)8-21)17-123-77(118)24-12-37(92)54(103)59(108)46(24)48-26(79(120)128-66)14-39(94)56(105)61(48)110/h1-15,43-44,65-70,81-111H,16-17H2/t43-,44-,65-,66-,67+,68+,69-,70-,81+,82+/m1/s1
Standard InChI Key: ZNCAVCXWFNHVHF-YLVKXZTISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1875.31 | Molecular Weight (Monoisotopic): 1874.1894 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Orabi MA, Taniguchi S, Sakagami H, Yoshimura M, Amakura Y, Hatano T.. (2016) Hydrolyzable Tannins of Tamaricaceous Plants. 7.1 Structures and Cytotoxic Properties of Oligomeric Ellagitannins from Leaves of Tamarix nilotica and Cultured Tissues of Tamarix tetrandra., 79 (4): [PMID:26938659] [10.1021/acs.jnatprod.5b01065] |
Source(1):